S&P 500
7,666.60
+35.13
+0.46%
Dow
53,061.95
+295.05
+0.56%
Nasdaq
26,217.83
+118.06
+0.45%
NYSE Composite
24,495.55
+146.25
+0.60%
Russell 2000
2,953.17
+33.04
+1.13%
VIX
15.34
+0.14
+0.92%
ABT · Abbott Laboratories
NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD
Abbott Laboratories (ABT)
NEW YORK STOCK EXCHANGE, INC.
Health Care
$110.46
+1.47
(+1.35%)
● At close: September 2 at 4:00:00 PM EDT
$110.47
-0.01
(-0.01%)
Pre-Market:
8:27:45 AM EDT
DAY'S RANGE
$110.46
$109.12
$112.18
52-WEEK RANGE
$110.46
$81.97
$137.49
What's happening
- ABT is up 1.35% today, trading at $110.46. — Live quote
- Volume today (412,007) is well below its 3-month average of 11,832,810. (Finnhub fundamentals)
- Last quarter's EPS beat estimates: $1.31 actual vs. $1.29 estimated (+1.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 12
Buy 13
Hold 8
Sell 0
Strong sell 0
Aggregate ratings for 2026-09-01 (33 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ABT
-13.06%
vs S&P 500
-24.77%
1-YEAR RETURN
ABT
-17.14%
vs S&P 500
-36.12%
6-MONTH RETURN
ABT
-6.30%
3-MONTH RETURN
ABT
+24.09%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$1.31
Est. $1.29
BEAT +1.4%
2026-04-26 (Q1 2026)
$1.15
Est. $1.16
MISS -0.5%
2026-01-26 (Q4 2025)
$1.50
Est. $1.51
MISS -0.7%
2025-10-26 (Q3 2025)
$1.30
Est. $1.31
MISS -1.1%
Valuation Measures & Ratios
Enterprise Value4$220.19B
Forward P/E518.11
PEG Ratio63.63
Price / Sales (TTM1)4.14
Price / Book73.09
EV4 / Revenue4.73
EV4 / EBITDA23.69
Profit Margin11.65%
Operating Margin15.83%
Return on Equity (ROE8)10.52%
Return on Assets (ROA9)5.56%
Avg Volume (3M)11,832,810
Quarterly history (5 periods)
| Measure | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 |
|---|---|---|---|---|---|
| Market cap | $178.80B | $228.88B | $233.00B | $223.99B | $191.43B |
| P/E | 30.70 | 35.80 | 38.50 | 40.74 | 34.13 |
| Price/Sales | 4.06 | 5.26 | 5.48 | 5.42 | 4.66 |
| Price/Book | 3.43 | 4.49 | 4.61 | 4.59 | 4.81 |
| EV/Revenue | 4.68 | 5.39 | 5.63 | 5.58 | 4.84 |
| ROE | 11.19% | 12.55% | 11.97% | 11.26% | 14.09% |
| ROA | 5.27% | 7.60% | 7.20% | 6.75% | 7.54% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E and PEG aren't shown here — both need historical analyst-consensus estimates, which no free source provides; see the current-period figures above instead.
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short20,375,133
Change from Prior Settlement-9.94%
% of Float—
Days to Cover (Short Ratio)2.86
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-08-14. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Signals describe daily price patterns—not the company’s value and not a recommendation to buy or sell. Read several together; no single indicator predicts what happens next. “Overbought” and “oversold” are conditions, not promises of a reversal.
Indicators None active
Loading chart…
Free IEX historical data only goes back to ~2021 — 5Y/Full show whatever's actually available, not a promise of that much history. Indicators are computed client-side from these same price bars; earnings markers ("E") come from Finnhub's free tier (~last 4 quarters + next upcoming) — older quarters aren't available. The move-highlight dots are a heuristic (|% change| vs rolling volatility) with a best-effort headline lookup, not a claim of causation.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 13.0% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 11.7%. Finnhub fundamentals ↗
Potential concerns
- Trailing 52-week price return is -17.1%. Finnhub market metrics ↗
- Trailing P/E is 35.5, a high price relative to reported earnings. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-08-27; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ABT
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 | Sep '23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.16B | $11.37B | $11.14B | $10.36B | $10.63B | $10.38B | $9.96B | $10.14B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $1.34B | $2.06B | $2.05B | $1.69B | $1.86B | $1.67B | $1.39B | $1.65B |
| Net income | $1.08B | $1.64B | $1.78B | $1.32B | $1.65B | $1.30B | $1.23B | $1.44B |
| EPS (diluted) | $0.61 | $0.94 | $1.01 | $0.76 | $0.94 | $0.74 | $0.70 | $0.82 |
| EPS (basic) | $0.62 | $0.94 | $1.02 | $0.76 | $0.94 | $0.74 | $0.70 | $0.82 |
| Operating margin | $12 | $18 | $18 | $16 | $17 | $16 | $14 | $16 |
| Net margin | $10 | $14 | $16 | $13 | $15 | $13 | $12 | $14 |
Balance sheet
| Line item | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $110.43B | $86.71B | $84.18B | $84.00B | $81.45B | $81.41B | $74.36B | $73.02B |
| Stockholders' equity | $52.06B | $52.13B | $50.95B | $50.56B | $48.81B | $47.66B | $39.80B | $39.32B |
| Total current assets | $25.51B | $26.00B | $24.84B | $24.47B | $23.15B | $23.66B | $23.80B | $23.12B |
| Total current liabilities | $18.38B | $16.50B | $14.58B | $13.44B | $13.00B | $14.16B | $14.90B | $13.76B |
| Cash & equivalents | $6.80B | $8.52B | $7.51B | $6.95B | $6.53B | $7.62B | $7.56B | $6.99B |
| Marketable securities (current) | $492.0M | $417.0M | $222.0M | $331.0M | $312.0M | $351.0M | $230.0M | $232.0M |
| Accounts receivable | $8.21B | $7.93B | $8.14B | $7.97B | $7.33B | $6.92B | $7.05B | $6.85B |
| Inventory | $6.99B | $6.49B | $6.71B | $6.95B | $6.64B | $6.19B | $6.81B | $6.81B |
| Other current assets | — | — | — | — | — | — | — | — |
| Marketable securities (non-current) | $1.09B | $918.0M | $951.0M | $958.0M | $907.0M | $886.0M | $912.0M | $877.0M |
| Property, plant & equipment | $12.38B | $11.82B | $11.50B | $11.39B | $10.93B | $10.66B | $10.62B | $10.23B |
| Goodwill | $35.22B | $24.04B | $23.97B | $23.95B | $23.36B | $23.11B | $23.66B | $23.31B |
| Intangible assets | $17.88B | $5.53B | $5.60B | $5.92B | $6.26B | $6.65B | $7.35B | $7.83B |
| Other non-current assets | — | — | — | — | — | — | — | — |
| Short-term debt | $4.41B | $3.03B | $1.34B | $507.0M | $506.0M | $1.50B | $2.15B | $1.61B |
| Long-term debt | $29.64B | $9.90B | $11.60B | $12.93B | $12.74B | $12.62B | $12.82B | $13.14B |
| Other non-current liabilities | — | $2.54B | — | — | — | $2.59B | — | — |
| Common stock & paid-in capital | $25.35B | $25.53B | $25.41B | $25.28B | $25.12B | $25.15B | $25.02B | $24.86B |
| Retained earnings | $49.96B | $49.78B | $49.10B | $48.47B | $47.72B | $47.26B | $39.06B | $38.35B |
| Accumulated other comprehensive income (loss) | -$6.31B | -$6.00B | -$6.68B | -$6.58B | -$7.42B | -$7.91B | -$7.80B | -$8.13B |
Cash flow
| Line item | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.31B | $3.31B | $2.79B | $2.05B | $1.42B | $2.87B | $2.71B | $1.96B |
| Investing cash flow | -$20.32B | -$913.0M | -$457.0M | -$582.0M | -$470.0M | -$866.0M | -$594.0M | -$453.0M |
| Financing cash flow | $17.31B | -$1.40B | -$1.76B | -$1.10B | -$2.06B | -$1.86B | -$1.58B | -$791.0M |
| Free cash flow | $916.0M | $2.63B | $2.29B | $1.54B | $933.0M | $2.15B | $2.15B | $1.43B |
| Capital expenditures | $399.0M | $689.0M | $496.0M | $502.0M | $484.0M | $720.0M | $556.0M | $533.0M |
| Share-based compensation | $317.0M | $113.0M | $120.0M | $142.0M | $289.0M | $111.0M | $117.0M | $141.0M |
| Deferred income taxes | — | $441.0M | — | — | — | -$7.96B | — | — |
| Change in accounts receivable | $42.0M | -$222.0M | $202.0M | $410.0M | $262.0M | $158.0M | $57.0M | $325.0M |
| Change in inventory | $420.0M | -$234.0M | -$213.0M | -$3.0M | $255.0M | -$235.0M | -$220.0M | $103.0M |
| Purchases of investments | — | $167.0M | — | — | — | $169.0M | — | — |
| Other investing activities | -$34.0M | -$6.0M | -$4.0M | -$2.0M | -$6.0M | -$4.0M | -$2.0M | -$2.0M |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | $180.0M | $302.0M | $305.0M | $6.0M | $280.0M | $315.0M | $751.0M | $3.0M |
| Debt issued | $19.86B | — | $0 | $2.0M | $1.0M | — | $1.0M | $221.0M |
| Debt repaid | $1.42B | — | $501.0M | $1.0M | $1.00B | — | $2.0M | $18.0M |
| Other financing activities | — | $0 | $0 | -$82.0M | — | $0 | $0 | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B |
| Operating income | $8.05B | $6.83B | $6.48B | $8.36B | $8.43B |
| Net income | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B |
| EPS (diluted) | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 |
| EPS (basic) | $3.73 | $7.67 | $3.28 | $3.94 | $3.97 |
| Operating margin | $18 | $16 | $16 | $19 | $20 |
| Net margin | $15 | $32 | $14 | $16 | $16 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $86.71B | $81.41B | $73.21B | $74.44B | $75.20B |
| Stockholders' equity | $52.13B | $47.66B | $38.60B | $36.69B | $35.80B |
| Total current assets | $26.00B | $23.66B | $22.67B | $25.22B | $24.24B |
| Total current liabilities | $16.50B | $14.16B | $13.84B | $15.49B | $13.11B |
| Cash & equivalents | $8.52B | $7.62B | $6.90B | $9.88B | $9.80B |
| Marketable securities (current) | $417.0M | $351.0M | $383.0M | $288.0M | $450.0M |
| Accounts receivable | $7.93B | $6.92B | $6.57B | $6.22B | $6.49B |
| Inventory | $6.49B | $6.19B | $6.57B | $6.17B | $5.16B |
| Other current assets | — | — | — | — | — |
| Marketable securities (non-current) | $918.0M | $886.0M | $799.0M | $766.0M | $816.0M |
| Property, plant & equipment | $11.82B | $10.66B | $10.15B | $9.16B | $8.96B |
| Goodwill | $24.04B | $23.11B | $23.68B | $22.80B | $23.23B |
| Intangible assets | $5.53B | $6.65B | $8.81B | $10.45B | $12.74B |
| Other non-current assets | — | — | — | — | — |
| Short-term debt | $3.03B | $1.50B | $1.08B | $2.25B | $754.0M |
| Long-term debt | $9.90B | $12.62B | $13.60B | $14.52B | $17.30B |
| Other non-current liabilities | $2.54B | $2.59B | $3.47B | $3.80B | $3.69B |
| Common stock & paid-in capital | $25.53B | $25.15B | $24.87B | $24.71B | $24.47B |
| Retained earnings | $49.78B | $47.26B | $37.55B | $35.26B | $31.53B |
| Accumulated other comprehensive income (loss) | -$6.00B | -$7.91B | -$7.84B | -$8.05B | -$8.37B |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $9.57B | $8.56B | $7.26B | $9.58B | $10.53B |
| Investing cash flow | -$2.42B | -$2.34B | -$3.13B | -$1.74B | -$2.01B |
| Financing cash flow | -$6.31B | -$5.40B | -$7.09B | -$7.64B | -$5.49B |
| Free cash flow | $7.39B | $6.35B | $5.06B | $7.80B | $8.65B |
| Capital expenditures | $2.17B | $2.21B | $2.20B | $1.78B | $1.89B |
| Share-based compensation | $664.0M | $673.0M | $644.0M | $685.0M | $640.0M |
| Deferred income taxes | $441.0M | -$7.96B | -$461.0M | -$659.0M | -$509.0M |
| Change in accounts receivable | $652.0M | $691.0M | $356.0M | $68.0M | $383.0M |
| Change in inventory | -$195.0M | $58.0M | $232.0M | $1.41B | $456.0M |
| Purchases of investments | $167.0M | $169.0M | $159.0M | $185.0M | $173.0M |
| Other investing activities | -$18.0M | -$9.0M | -$22.0M | -$22.0M | -$26.0M |
| Dividends paid | — | — | — | — | — |
| Share repurchases | $893.0M | $1.29B | $1.23B | $3.79B | $2.30B |
| Debt issued | — | — | — | — | $4.0M |
| Debt repaid | — | — | — | — | $48.0M |
| Other financing activities | -$82.0M | $0 | $0 | $0 | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ABT as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 31 filers
Held by These Filers54.8%
Shares Outstanding1,740,420,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 152,563,476 | $13.84B | 8.77% | +4.7% | 2026-08-07 |
| VANGUARD CAPITAL MANAGEMENT LLC | 113,750,994 | $10.32B | 6.54% | +0.7% | 2026-06-30 |
| State Street Corp | 80,926,234 | $7.34B | 4.65% | +1.7% | 2026-08-07 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 59,674,507 | $5.41B | 3.43% | +31.2% | 2026-08-14 |
| Sixth Street Partners Management Company, L.P. | 59,674,507 | $5.41B | 3.43% | +0.0% | 2026-08-13 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 49,017,866 | $4.45B | 2.82% | +2.2% | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 39,219,337 | $3.54B | 2.25% | +0.2% | 2026-08-12 |
| Capital Research Global Investors | 36,908,990 | $3.35B | 2.12% | -25.8% | 2026-08-07 |
| Capital International Investors | 34,654,113 | $3.15B | 1.99% | -7.6% | 2026-08-07 |
| Morgan Stanley | 26,611,314 | $2.41B | 1.53% | -11.6% | 2026-08-11 |
| NORGES BANK | 23,354,911 | $2.12B | 1.34% | +0.0% | 2026-08-12 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 22,787,202 | $2.1M | 1.31% | +31.9% | 2026-08-14 |
| Franklin Resources Inc | 18,806,911 | $1.71B | 1.08% | -6.1% | 2026-08-04 |
| Northern Trust Corp | 18,273,301 | $1.66B | 1.05% | -5.8% | 2026-08-12 |
| Bank Of America Corp /De/ | 17,672,543 | $1.60B | 1.02% | -8.3% | 2026-08-14 |
| Goldman Sachs Group Inc | 16,760,070 | $1.52B | 0.96% | +15.5% | 2026-08-14 |
| DEUTSCHE BANK AG\ | 16,706,669 | $1.52B | 0.96% | +18.6% | 2026-08-07 |
| Wells Fargo & Company/Mn | 15,177,317 | $1.38B | 0.87% | -4.6% | 2026-08-14 |
| Jpmorgan Chase & Co | 15,095,898 | $1.40B | 0.87% | -43.6% | 2026-08-12 |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 13,587,118 | $1.23B | 0.78% | +0.0% | 2026-07-28 |
| FMR LLC | 13,423,080 | $1.22B | 0.77% | +23.8% | 2026-08-13 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 13,359,956 | $1.22B | 0.77% | -13.8% | 2026-08-03 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 12,835,753 | $1.16B | 0.74% | -2.8% | 2026-08-13 |
| Legal & General Group Plc | 11,929,958 | $1.08B | 0.69% | -2.9% | 2026-08-14 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 10,897,178 | $988.8M | 0.63% | +97.3% | 2026-08-13 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-04-23 to 2026-08-25
Recent transactions
- Insiders have net sold 390,482 shares over the last 182 days, across 3 purchases and 3 sales.
- Most recent: Ford Robert B (CHAIRMAN AND CEO) — Option exercise of 151,869 shares on 2026-08-25.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)14,200 sh(3 txns)
Sales (open market)404,682 sh(3 txns)
Net Shares-390,482
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Ford Robert B | CHAIRMAN AND CEO | Option exercise | 2026-08-25 | 151,869 |
| Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Code I | 2026-08-12 | 12 |
| Cushman Elizabeth C. | EVP, GC AND SECRETARY | Tax withholding | 2026-06-27 | 560 |
| Stratton John G | Reporting person | Open market purchase | 2026-05-07 | 2,000 |
| Moreland Mary K | EXECUTIVE VICE PRESIDENT | Code I | 2026-04-28 | 5,314 |
| STARKS DANIEL J | Reporting person | Open market purchase | 2026-04-27 | 10,000 |
| Conroy Kevin T | Reporting person | Grant / award | 2026-04-24 | 2,286 |
| Roman Michael F | Reporting person | Grant / award | 2026-04-24 | 2,286 |
| O'Grady Michael | Reporting person | Grant / award | 2026-04-24 | 2,286 |
| McKinstry Nancy | Reporting person | Grant / award | 2026-04-24 | 2,286 |
| McDew Darren W | Reporting person | Grant / award | 2026-04-24 | 2,286 |
| Kumbier Michelle | Reporting person | Grant / award | 2026-04-24 | 2,286 |
| Gonzalez Patricia Paola | Reporting person | Grant / award | 2026-04-24 | 2,286 |
| Blount Sally E. | Reporting person | Grant / award | 2026-04-24 | 2,286 |
| Babineaux-Fontenot Claire | Reporting person | Grant / award | 2026-04-24 | 2,286 |
| Ahuja Nita | Reporting person | Grant / award | 2026-04-24 | 2,286 |
| Boudreau Philip P | EVP AND CFO | Code I | 2026-04-23 | 8,909 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-25 | Ford Robert B | CHAIRMAN AND CEO | Option exercise | 151,869 | $44.40 |
| 2026-08-25 | Ford Robert B | CHAIRMAN AND CEO | Option exercise | 246,963 | $59.94 |
| 2026-08-25 | Ford Robert B | CHAIRMAN AND CEO | Open market sale | 218,535 | $115.57 |
| 2026-08-25 | Ford Robert B | CHAIRMAN AND CEO | Open market sale | 180,297 | $116.19 |
| 2026-08-12 | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Code I | 12 | $107.99 |
| 2026-08-11 | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Open market sale | 5,850 | $109.83 |
| 2026-06-30 | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Tax withholding | 269 | $92.71 |
| 2026-06-27 | Cushman Elizabeth C. | EVP, GC AND SECRETARY | Tax withholding | 560 | $94.12 |
| 2026-05-07 | Stratton John G | Reporting person | Open market purchase | 2,000 | $86.82 |
| 2026-04-28 | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Code I | 5,314 | $94.41 |
| 2026-04-27 | STARKS DANIEL J | Reporting person | Open market purchase | 10,000 | $92.65 |
| 2026-04-24 | Conroy Kevin T | Reporting person | Grant / award | 2,286 | $0.00 |
| 2026-04-24 | Stratton John G | Reporting person | Grant / award | 2,286 | $0.00 |
| 2026-04-24 | STARKS DANIEL J | Reporting person | Grant / award | 2,286 | $0.00 |
| 2026-04-24 | Roman Michael F | Reporting person | Grant / award | 2,286 | $0.00 |
| 2026-04-24 | O'Grady Michael | Reporting person | Grant / award | 2,286 | $0.00 |
| 2026-04-24 | McKinstry Nancy | Reporting person | Grant / award | 2,286 | $0.00 |
| 2026-04-24 | McDew Darren W | Reporting person | Grant / award | 2,286 | $0.00 |
| 2026-04-24 | Kumbier Michelle | Reporting person | Grant / award | 2,286 | $0.00 |
| 2026-04-24 | Gonzalez Patricia Paola | Reporting person | Grant / award | 2,286 | $0.00 |
| 2026-04-24 | Blount Sally E. | Reporting person | Grant / award | 2,286 | $0.00 |
| 2026-04-24 | Babineaux-Fontenot Claire | Reporting person | Grant / award | 2,286 | $0.00 |
| 2026-04-24 | Ahuja Nita | Reporting person | Grant / award | 2,286 | $0.00 |
| 2026-04-23 | Boudreau Philip P | EVP AND CFO | Code I | 8,909 | $92.04 |
| 2026-04-23 | Boudreau Philip P | EVP AND CFO | Open market purchase | 2,200 | $91.50 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-09-03 12:38 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-27 | 4 | 2026-08-25 | View on SEC.gov → |
| 2026-08-20 | 8-K | 2026-08-20 | View on SEC.gov → |
| 2026-08-13 | 4 | 2026-08-11 | View on SEC.gov → |
| 2026-07-28 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-16 | 8-K | 2026-07-16 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-06-29 | 4 | 2026-06-27 | View on SEC.gov → |
Recent news
Headlines about ABT (Abbott Laboratories). Links open the publisher — we don’t host full articles.
-
Abbott (ABT) Exceeds Market Returns: Some Facts to Consider
Yahoo · 2026-09-02 -
The Wide Divide Priced Into Boston Scientific Stock
Yahoo · 2026-09-02 -
Median Technologies Announces Formation of Strategic Review Committee and R&D Committee to Unlock Intrinsic Value and Accelerate Its eyonis® Pan-Cancer Strategy
Yahoo · 2026-09-02 -
3 Reasons to Sell PACB and 1 Stock to Buy Instead
Yahoo · 2026-09-02 -
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
Yahoo · 2026-09-02 -
Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?
Yahoo · 2026-09-02 -
Medtronic Begins Fiscal 2027 With a Beat-and-Raise, Validating Growth Acceleration, RBC Says
Yahoo · 2026-09-02 -
Ecora Resources H1 Earnings Call Highlights
Yahoo · 2026-09-02
No headlines in this category right now — try “All”.